Novartis reported fourth-quarter 2022 sales of $12.7 billion. This represents a decrease of four percent compared to the same period last year, when $13.2 billion was generated. At constant exchange rates, there was an increase of three percent. The period was characterized by volume increases partially absorbed by...
In early 2023, Sanofi Ventures received a commitment from its parent company for an additional multi-year commitment. The capital will be increased to more than 750 million dollar for the "evergreen venture fund." This venture capital fund focuses on early-stage investments, co-creating companies and leading financing...
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that its long-standing client, Chiesi Group, recently presented Rentschler Biopharma with the “We Excel in Innovation and Collaboration Award”. During Chiesi Group’s Vendor Day,...
Gerresheimer and Stevanato Group announce that they have jointly developed a high-end ready-to-use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill technology. This collaboration is projected to help customers gain efficiencies, improve the quality standard,...
Michael Sen (53) will become Chief Executive Officer of Fresenius on October 1, 2022. He was appointed unanimously by the Supervisory Board of Fresenius Management SE today to succeed Stephan Sturm (59), who will leave the company on good terms on September 30. Michael Sen will, in addition, continue to serve as CEO of...
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is expanding its Leadership Team with two experienced leaders in the areas of strategy and law. These newly created internal advisory functions will play an important role in the continued...
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) provided an update on progress at Rentschler ATMP Ltd., the Company’s dedicated cell and gene therapy facility located in Stevenage, UK, including an important key hire. The Company has recently hired Kassim Kolia as Vice...
Curevac is acquiring privately held Frame Cancer Therapeutics, which focuses on advanced genomics and bioinformatics to identify both unique and common neoantigens for various cancers. "Embedding Frame's technology and expertise into Curevac's oncology research complements our ability to identify and validate promising...
Evonik is building a new, highly flexible world-scale production facility for pharmaceutical lipids in the USA. The new facility at Evonik's Tippecanoe site in Lafayette, Indiana, will broadly position the company for future growth in new type mRNA-based therapies beyond Covid-19 vaccines. Construction will begin in...
Merck achieved a strong result in the 1st quarter of 2022. Sales rose 12.2 percent year-on-year to around EUR 5.2 billion. The main growth drivers were the Process Solutions business of Life Science, new healthcare products and the Semiconductor Solutions business of Electronics. Organic growth in Group sales totaled 7...
